Announced Wed, 15 Jul · 17:54 IST
Drug license suspended for 3 Karnataka stores via subsidiary
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹805.00
prior close
₹805.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.2+0.2—-0.5-0.5-1.7-11.7-11.1-10.6————
Up moveDown movePending
AI summary
Optival Health Solutions, a subsidiary of MedPlus, received three drug license suspension orders for stores in Karnataka from the Drugs Control Administration. One-day suspensions for Sarakki JP Nagar Metro Station and Jaraganahalli stores, and a two-day suspension for K C Road Chikkodi store. Combined potential revenue loss is about Rs 1.59 lacs. Orders issued under Rule 65 of the Drugs and Cosmetics Act, 1940.
Likely market impact
Revenue impact negligible at about Rs 1.59 lacs total. Minor regulatory issue, unlikely to materially affect operations or share price.